These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
218 related articles for article (PubMed ID: 6267464)
1. Reversible inhibition of testicular steroidogenesis and spermatogenesis by a potent gonadotropin-releasing hormone agonist in normal men: an approach toward the development of a male contraceptive. Linde R; Doelle GC; Alexander N; Kirchner F; Vale W; Rivier J; Rabin D N Engl J Med; 1981 Sep; 305(12):663-7. PubMed ID: 6267464 [TBL] [Abstract][Full Text] [Related]
2. Intermittent long-term administration of a potent gonadotropin-releasing hormone agonist in normal men. Doelle G; Linde R; Alexander N; Kirchner F; Vale W; Rivier J; Rabin D Int J Fertil; 1982; 27(4):234-7. PubMed ID: 6131043 [TBL] [Abstract][Full Text] [Related]
3. Gonadotropin releasing hormone (GnRH) agonists in male contraception. Swerdloff RS; Steiner BS; Bhasin S Med Biol; 1986; 63(5-6):218-24. PubMed ID: 2939304 [TBL] [Abstract][Full Text] [Related]
4. Short-term treatment of idiopathic precocious puberty with a long-acting analogue of luteinizing hormone-releasing hormone. A preliminary report. Comite F; Cutler GB; Rivier J; Vale WW; Loriaux DL; Crowley WF N Engl J Med; 1981 Dec; 305(26):1546-50. PubMed ID: 6458765 [TBL] [Abstract][Full Text] [Related]
5. Hormonal effects of gonadotropin-releasing hormone (GnRH) agonist in the human male. III. Effects of long term combined treatment with GnRH agonist and androgen. Bhasin S; Heber D; Steiner BS; Handelsman DJ; Swerdloff RS J Clin Endocrinol Metab; 1985 May; 60(5):998-1003. PubMed ID: 3920237 [TBL] [Abstract][Full Text] [Related]
6. Comparison of a gonadotropin releasing-hormone antagonist plus testosterone (T) versus T alone as potential male contraceptive regimens. Bagatell CJ; Matsumoto AM; Christensen RB; Rivier JE; Bremner WJ J Clin Endocrinol Metab; 1993 Aug; 77(2):427-32. PubMed ID: 8345047 [TBL] [Abstract][Full Text] [Related]
7. Gonadotropin and steroid secretory patterns during chronic treatment with a luteinizing hormone-releasing hormone agonist analog in men. Evans RM; Doelle GC; Alexander AN; Uderman HD; Rabin D J Clin Endocrinol Metab; 1984 May; 58(5):862-7. PubMed ID: 6423661 [TBL] [Abstract][Full Text] [Related]
9. Chronic treatment with the gonadotropin-releasing hormone agonist D-Ser(TBU)6-EA10-LRH for contraception in women and men. Nillius SJ; Bergquist C; Wide L Int J Fertil; 1980; 25(3):239-46. PubMed ID: 6108935 [TBL] [Abstract][Full Text] [Related]
10. Endocrine effects of combined treatment with an LHRH agonist in association with flutamide in metastatic prostatic carcinoma. Bélanger A; Labrie F; Dupont A; Brochu M; Cusan L Clin Invest Med; 1988 Oct; 11(5):321-6. PubMed ID: 2972431 [TBL] [Abstract][Full Text] [Related]
11. The biologic activity of a potent analogue of gonadotropin-releasing hormone in normal and hypogonadotropic men. Crowley WF; Beitins IZ; Vale W; Kliman B; Rivier J; Rivier C; McArthur JW N Engl J Med; 1980 May; 302(19):1052-7. PubMed ID: 6767977 [TBL] [Abstract][Full Text] [Related]
13. Testicular function after orchiopexy for unilaterally undescended testis. Lipshultz LI; Caminos-Torres R; Greenspan CS; Snyder PJ N Engl J Med; 1976 Jul; 295(1):15-8. PubMed ID: 5671 [TBL] [Abstract][Full Text] [Related]
14. Testosterone suppression of the HPT axis. MacIndoe JH; Perry PJ; Yates WR; Holman TL; Ellingrod VL; Scott SD J Investig Med; 1997 Oct; 45(8):441-7. PubMed ID: 9394096 [TBL] [Abstract][Full Text] [Related]
15. Partial prevention of procarbazine induced germinal cell aplasia in rats by sequential GnRH antagonist and testosterone administration. Pogach LM; Lee Y; Gould S; Giglio W; Huang HF Cancer Res; 1988 Aug; 48(15):4354-60. PubMed ID: 3134124 [TBL] [Abstract][Full Text] [Related]
16. Effects of pituitary-testicular axis suppression in utero and during the early neonatal period with a long-acting luteinizing hormone-releasing hormone analog on genital development, somatic growth, and bone density in male cynomolgus monkeys in the first 6 months of life. Liu L; Cristiano AM; Southers JL; Reynolds JC; Bacher J; Brown G; Gilley RM; Tice TR; Banks SM; Loriaux LD J Clin Endocrinol Metab; 1991 Nov; 73(5):1038-43. PubMed ID: 1939516 [TBL] [Abstract][Full Text] [Related]
17. Treatment of men with paraphilia with a long-acting analogue of gonadotropin-releasing hormone. Rösler A; Witztum E N Engl J Med; 1998 Feb; 338(7):416-22. PubMed ID: 9459644 [TBL] [Abstract][Full Text] [Related]
18. Effects of an LHRH agonist analog upon sexual function in male dogs. Suppression, reversibility, and effect of testosterone replacement. Vickery BH; McRae GI; Briones W; Worden A; Seidenberg R; Schanbacher BD; Falvo R J Androl; 1984; 5(1):28-42. PubMed ID: 6231277 [TBL] [Abstract][Full Text] [Related]
19. Inability of continuous long-term administration of D-Nal(2)6-LHRH to abolish fertility in male rats. Vickery BH; McRae GI; Bergstrom K; Briones W; Worden A; Seidenberg R J Androl; 1983; 4(4):283-91. PubMed ID: 6225758 [TBL] [Abstract][Full Text] [Related]
20. Treatment of young rams with an agonist of GnRH delays reproductive development. Tilbrook AJ; Galloway DB; Williams AH; Clarke IJ Horm Behav; 1993 Mar; 27(1):5-28. PubMed ID: 8440517 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]